Quality of life assessment in reflux disease

European Journal of Gastroenterology and Hepatology

Volumn 10, Issue 6, 1998, Pages 451-454

  Tebaldi, Morena ^a   Heading, Robert C ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Gastro oesophageal reflux; Oesophagitis; Quality of life

Indexed keywords

GASTROESOPHAGEAL REFLUX; HEALTH STATUS; HEARTBURN; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT SURVEY; STOMACH ACID; TREATMENT OUTCOME; WELLBEING;

EID: 0031746321     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199806000-00002     Document Type: Short Survey

References (11)

1. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112:1448-1456.
2. McDougall NI, Collins JSA, McFarland RJ, Watson RGP, Love AHG. The effect of treating oesophagitis with omeprazole on quality of life. Eur J Gastroenterol Hepatol 1998; 10:459-464
3. Dixon P, Heaton J, Long A, Warburton A. Reviewing and applying the SF-36. Outcomes Briefing 1994; 4:2-25.
4. Hahn BA, Kirchdoerfer U, Fullerton S, Mayers E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resources utilisation and quality of life. Aliment Pharmacol Ther 1997; 11:553-559.
5. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, et al. Functional status and well-being of patients with chronic conditions. Results from the medical outcomes study. J Am Med Assoc 1989; 262:907-913.
6. Hallerback B. Assessment of quality of life among patients with suspected duodenal ulcer. Scand J Gastroenterol 1993; 28(Suppl 199):32-33.
7. McDougall NI, Johnston BT, Kee F, Collins JSA, McFarland RJ, Love AHG. Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut 1996; 38:481-486.
8. Glise H. Quality of life and cost of therapy in reflux disease. Scand J Gastroenterol 1995; 29(Suppl 210):681-687.
9. Glise H, Hallerback B, Johansson B. Quality of life assessments in the evaluation of gastroesophageal reflux and peptic ulcer disease before, during and after treatment. Scand J Gastroenterol 1995; 30(Suppl 208):133-135.
10. Arledge TE, Osterhause JT, Euler AR, Kirchdoerfer LJ, Murdock RH, Johnson JA. Ranitidine therapy improves quality of life in patients with gastroesophageal reflux disease. Gastroenterology 1992; 102(Suppl):A34.
11. Eggleston A, Wigerinck A, Huijghebaert S, Dubois D, Haycox A. Cost effectiveness of treatment for gastro-oesophageal reflux disease in clinical practice: a clinical database analysis. Gut 1998; 42:13-16.